Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern

Most current anti-viral vaccines elicit a humoral and cellular immune response via the pathway of phagocytic cell mediated viral antigen presentation to B and T cell surface receptors. However, this pathway results in reduced ability to neutralize S-protein Receptor Binding Domains (RBDs) from sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Steven Y., Amaro-Mugridge, Nancy B., Madrid-Weiss, Jocelyn, Petkovic, Nikolina, Vanegas, Natasha, Visvanathan, Kumar, Williams, Bryan R. G., MacDiarmid, Jennifer A., Brahmbhatt, Himanshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929940/
https://www.ncbi.nlm.nih.gov/pubmed/36818474
http://dx.doi.org/10.3389/fimmu.2022.1038562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9929940/
https://www.ncbi.nlm.nih.gov/pubmed/36818474
http://dx.doi.org/10.3389/fimmu.2022.1038562

Ejemplares similares